- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 10, 2025 | 12.38M sh |
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $106.85K |
| Long Term Debt | Q3 2025 · Jun 30, 2024 | $123.86K |
| Short Term Debt | Q3 2025 · Mar 31, 2025 | $867.27K |
| Short Term Debt | Q3 2025 · Jun 30, 2024 | $574.24K |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $17.33M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $10.38M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $13.32M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $10.47M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $27.82M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $12.75M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $35.27M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $24.59M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $67.1M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $35.17M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 9.69M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 9.69M sh |
| Capex | Q3 2025 · Mar 31, 2024 | $408.39K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $2.67M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $19.58M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $17.78M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | $16.49M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $15.42M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.19 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.43 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.19 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.45 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $3.31M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $9.75M |
| Net Income | Q3 2025 · Mar 31, 2024 | $1.79M |
| Net Income | Q3 2025 · Mar 31, 2024 | $4.15M |
| Net Income | Q3 2025 · Dec 31, 2023 | $1.29M |
| Net Income | Q3 2025 · Sep 30, 2023 | $1.07M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $2.37M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $5.38M |
| Revenue | Q3 2025 · Mar 31, 2024 | $12.33M |
| Revenue | Q3 2025 · Mar 31, 2024 | $33.25M |